Milk allergy immunotherapy companion diagnostic - DBV TechnologiesAlternative Names: Diallertest
Latest Information Update: 22 Nov 2014
At a glance
- Originator DBV Technologies
- Class Protein diagnostics
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Milk hypersensitivity
Most Recent Events
- 20 Nov 2014 Clinical trials in Milk hypersensitivity (In adolescents, In children, Diagnosis) in Canada (Topical)